Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

OBJECTIVE: Obtain a more precise estimate of the efficacy of delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) in relapsing multiple sclerosis (MS) and examine the consistency of DMF's effects across patient subgroups stratified by baseline demographic and disease char...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Clin Transl Neurol
Auteurs principaux: Viglietta, Vissia, Miller, David, Bar-Or, Amit, Phillips, J Theodore, Arnold, Douglas L, Selmaj, Krzysztof, Kita, Mariko, Hutchinson, Michael, Yang, Minhua, Zhang, Ray, Dawson, Katherine T, Sheikh, Sarah I, Fox, Robert J, Gold, Ralf
Format: Artigo
Langue:Inglês
Publié: BlackWell Publishing Ltd 2015
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338952/
https://ncbi.nlm.nih.gov/pubmed/25750916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.148
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires